Anjalee Khemlani
@AnjKhem
Senior Health Reporter @YahooFinance Information is my oxygen| Also on sky| Sig anjkhem.01
What's the over-under on how long this stand-off lasts? @PharmaPinkSheet @ScripMandy: Sarepta Refuses To Stop Elevidys Shipments After Third Death Linked To Gene Therapy Vector insights.citeline.com//pink-sheet/ad…
Sarepta $SRPT maybe recovering today, though still down about 5% in early trading finance.yahoo.com/news/sarepta-t…
Elon Musk’s brain implant company Neuralink expects to put its chips in 20,000 people a year by 2031, generating at least $1 billion in annual revenue bloomberg.com/news/articles/… via @business
The protein boom is only beginning finance.yahoo.com/news/the-prote…
A judge blocked a rule to drop medical debt from credit reports. What now? finance.yahoo.com/news/a-judge-b…
China innovation and deals are good for (global) biotech: AstraZeneca CEO $AZN finance.yahoo.com/news/china-inn…
$AZN has announced a $50 billion investment in the US amid increased pressure from President Trump to reshore domestic production. "This investment is really to fuel our growth and, in part, address the tariff issue," CEO Pascal Soriot told @AnjKhem. Full comments:
Sarepta Therapeutics stock sinks further Tuesday after halting shipment of bestselling drug Elevidys $SRPT finance.yahoo.com/news/sarepta-t…
Sarepta halts US shipments of Duchenne therapy, bowing to FDA endpoints.news/sarepta-halts-…
NEW: $AZN AstraZeneca announces $50B manufacturing investment in US. Matching big pharma peers of $55B (J&J) and $50B (Eli Lilly). finance.yahoo.com/news/astrazene…
A large study including more than 130,000 people in the U.S. revealed that the shingles vaccine (Shingrix) and the respiratory syncytial virus (RSV) vaccine (Arexyv) are associated with a reduced risk of dementia. sciencealert.com/huge-study-rev…
Sarepta Therapeutics has refused the FDA’s request that it pull gene therapy from the market following patient deaths statnews.com/2025/07/18/sar…
That is quite a lot of value destruction. 90%+ gone in 12 months. $SRPT
An absolutely stunning 48 hours for Sarepta, its leadership and the patients they serve. endpoints.news/fda-asks-sarep…
NEWS: Another looming health crisis for Trump -- insurers in many states seek to jack up their premiums in part because of GOP policies. If Obamacare subsidies also get cut, monthly bills will skyrocket. By @Julie_appleby kffhealthnews.org/news/article/o…
Trump’s Budget And Tariffs Fuel 15% Hike In Individual Health Premiums via @forbes forbes.com/sites/brucejap…
The tide of US government money that has been pouring into health insurers for decades is reversing more abruptly than expected, putting strategies that drove profit growth for years in doubt bloomberg.com/news/articles/…
Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings via @forbes forbes.com/sites/brucejap…
A well-placed biotech investor says U.S. policies are straining life sciences startups statnews.com/2025/07/15/bio… via @ADeAngelis_bio